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COVID-19: long-term effects on the community response to 
cardiac arrest?
In The Lancet Public Health, Eloi Marijon and colleagues 
suggest that out-of-hospital cardiac arrest (OHCA) 
might be affected directly and indirectly by the COVID-19 
pandemic.1 The authors used the Paris-Sudden Death 
Expertise Center registry to compare OHCA case 
incidence and patient characteristics from a 6-week 
period during the COVID-19 pandemic in Paris and its 
suburbs (March 16 to April 26, 2020) with corresponding 
periods over the preceding 8 years. The rapid publication 
of this Article shows the value of cardiac arrest registries 
and other disease registries in highlighting changes in 
practice and informing policy interventions.
During the 6-week pandemic period in Paris, OHCA 
incidence approximately doubled from a baseline of 
13·42 (95% CI 12·77–14·07) to 26·64 (25·72–27·53) 
per million inhabitants. The incidence of OHCA rose in 
parallel with the incidence of COVID-19 related hospital 
admissions. Similar patterns in OHCA incidence have 
been observed in the Lombardy region of Italy2 and 
California, USA.3 Importantly, in the study by Marijon 
and colleagues, OHCA incidence decreased towards 
baseline near the end of the 6-week period in line with a 
decrease in COVID-19 incidence.
Putative mechanisms by which COVID-19 might cause 
cardiac arrest include vascular inflammation, myocarditis, 
cardiac arrythmias, and thromboembolism.4 However, 
in the present study, only 33% of the increase in OHCA 
cases were directly attributable to COVID-19, making 
indirect effects a substantial component. Indirect effects 
could arise from fear and anxiety reducing or delaying 
presentation for non-COVID-19 related conditions such 
as acute coronary syndromes, one of the commonest 
antecedents to cardiac arrest.3,5 Social isolation can 
worsen mental health increasing self-harm and substance 
use precipitating cardiac arrest. A better understanding 
of the causes of the excess cardiac arrest numbers will 
be important to help plan public health interventions to 
reduce OHCA incidence.
Across study periods, patient characteristics were 
similar, but important differences in event characteristics 
were observed. In the COVID-19 period, around 13% 
(460 [90·2%] vs 2336 [76·8%]) more cases occurred 
inside the home than in the non-pandemic period. Fewer 
patients presented with shockable rhythm (46 [9·2%] 
vs 472 [19·1%]), received bystander cardiopulmonary 
resuscitation (CPR; 239 [47·8%] vs 1165 [63·9%]), and 
public access defibrillation (2 [0·4%] vs 33 [3·0%]). 
Ambulance response times were longer and the 
proportion of OHCAs where the ambulance crew started 
or continued resuscitation was lower than usual (53·1% vs 
66·2%) during the pandemic period.
Of concern, fewer patients survived to hospital 
admission (67 [12·9%] of 521 vs 695 [22·8%] of 3052) 
and fewer survived to hospital discharge (16 [3·1%] 
of 517 vs 164 [5·4%] of 3052). The finding that the 
proportion of OHCAs with resuscitation attempt was 
lower than usual might partly account for the lower 
survival rate. Whether this observation is explained by 
a higher proportion of patients presenting with signs of 
irreversible death, do not attempt resuscitation orders, 
or changes in ambulance crew behaviour due to fear 
of infection or perceptions that the health system was 
overwhelmed is worthy of further exploration.
Another important finding is lower rates of bystander 
CPR and public access defibrillation, similar to findings 
in Lombardy.2 The community response to OHCA plays 
a key role in optimising patient outcomes, increasing 
survival by 2–4 times.6 Despite ongoing efforts to 
improve this community response, there continues to 
be important international variation in performance. 
Across international cardiac arrest registries, bystander 
CPR rates range from 19·1% to 79·0%, and public access 
defibrillation use ranges from 2·0% to 37·4%.7
The reason for the observed decline in bystander 
CPR is unclear. Some potential causes might naturally 
resolve as society leaves lockdown and the proportion 
of OHCA events that occur in the home decreases and 
community responder schemes are reactivated. Other 
causes, such as the often-cited concern of contracting an 
infection through delivery of CPR, are likely to increase 
in prevalence.
The International Liaison Committee on Resuscitation 
treatment recommendations for resuscitation in 
COVID-19 seek to balance the potential risk of infection 
transmission to the rescuer against the harm to the 
patient if resuscitation is delayed or withheld.8,9 These 
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recommendations highlight that particularly when 
cardiac arrest occurs in the home, those available to 
provide immediate CPR and defibrillation are likely 
to already be exposed to COVID-19 if the recipient 
has it. Simple interventions such as placing a cloth or 
mask over the patient’s mouth and providing chest 
compression only resuscitation allow resuscitation to be 
started with minimal delay.10
Health-care providers are advised to wear personal 
protective equipment for aerosol generating procedures 
when attempting CPR in patients with suspected or 
confirmed COVID-19.9,10 It is possible that this additional 
measure contributed to the observed treatment delays. 
However, in this study in Paris, fewer than 10% of all 
patients who had an OHCA had known or suspected 
COVID-19.1 Policy makers will, at some point, need to 
consider the ongoing need for COVID-19 resuscitation 
guidelines based on disease incidence within the local 
health-care system.
Over subsequent months, there is a need for further 
studies to identify the medium-term effect of COVID-19 
on OHCA. There is a risk that the COVID-19 pandemic 
could undo the substantial progress that has been 
made in optimising the community response to OHCA. 
Identification and quantification of this risk might 
highlight the urgent need for public health interventions 
to rebuild public confidence in responding to OHCA. 
Otherwise, the indirect health impact of COVID-19 on 
OHCA could persist for many years into the future.
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